- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2015
- Public Summary Document (PSD) March 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2015 PBAC Meeting - Word
Ledipasvir with sofosbuvir – March 2015
Ledipasvir with sofosbuvir; ledipasvir 90 mg + sofosbuvir 400 mg tablet 28; Harvoni®
Last updated
3 July 2015
